Sana Qadir
Sana Qadir has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Hafiz Muhammad Aslam
Hematology and Medical Oncology, East Carolina University, Greenville, USA
2 shared publications - Shumaila M. Iqbal
Internal Medicine, University at Buffalo / Sisters of Charity Hospital, Buffalo, USA
2 shared publications - Faizan Faizee
Internal Medicine, Dow University of Health Sciences (DUHS), Karachi, PAK
1 shared publication Madiha A Qadir
Internal Medicine, Jinnah Sindh Medical University, Karachi, PAK
1 shared publication- Saadia Waheed
Internal Medicine, University at Buffalo / Sisters of Charity Hospital, Buffalo, USA
1 shared publication
Latest Publications
- Open Access
- 7 January 2019
- Published by Springer Nature in Cureus
- Vol. 11 (1) , e3840
Updated Treatment for Calcium Pyrophosphate Deposition Disease: An Insight
Calcium pyrophosphate disease (CPPD) is caused by the deposition of calcium pyrophosphate (CPP) crystals in the joint tissues, particularly fibrocartilage and hyaline cartilage. CPP crystals trigger inflammation, causing local articular tissue damage. Our review article below covers different aspects of CPPD. It discusses how CPPD can manifest as different kinds of arthritis, which may be symptomatic or asymptomatic. The metabolic and endocrine disease associations and routine investigations used in the diagnostic workup are briefly reviewed. Conventional and newer therapies for the treatment of CPPD are outlined. Overall, this extensive review would provide an updated insight to clinicians for evidence-based treatment of CPPD.
- 7 January 2019
- Published by Springer Nature in Cureus
- Vol. 11 (1) , e3840
Open AccessUpdated Treatment for Calcium Pyrophosphate Deposition Disease: An Insight
Calcium pyrophosphate disease (CPPD) is caused by the deposition of calcium pyrophosphate (CPP) crystals in the joint tissues, particularly fibrocartilage and hyaline cartilage. CPP crystals trigger inflammation, causing local articular tissue damage. Our review article below covers different aspects of CPPD. It discusses how CPPD can manifest as different kinds of arthritis, which may be symptomatic or asymptomatic. The metabolic and endocrine disease associations and routine investigations used in the diagnostic workup are briefly reviewed. Conventional and newer therapies for the treatment of CPPD are outlined. Overall, this extensive review would provide an updated insight to clinicians for evidence-based treatment of CPPD.
- Open Access
- 27 September 2018
- Published by Cureus, Inc. in Cureus
- Vol. 10 (9) , e3372
Pseudogout: An Autoimmune Paraneoplastic Manifestation of Myelodysplastic Syndrome
Myelodysplastic syndrome (MDS) is often associated with autoimmune paraneoplastic manifestations. Seronegative arthritis is among one of them. Very rarely, pseudogout demonstrated as paraneoplastic autoimmune manifestations of MDS has been adumbrated so far. Our case would be the another addition in the series. Our patient is an 83-year-old male lately diagnosed with MDS. After six months of initial diagnosis, he had a sudden onset episode of pain and swelling involving left wrist. Synovial fluid analysis from respective radiocarpal joint confirmed the presence of intracellular positively birefringent rhomboid shaped crystals of calcium pyrophosphate dihydrate (CPPD). This was followed by another two flares of pseudogout involving right knee and lumbar spine at separate time intervals. Each of the episodes mentioned above responded well to intravenous and oral steroids. After the third bout, he was started treatment with azacitidine which showed effective abatement of further episodes of pseudogout up until now.
- 27 September 2018
- Published by Cureus, Inc. in Cureus
- Vol. 10 (9) , e3372
Open AccessPseudogout: An Autoimmune Paraneoplastic Manifestation of Myelodysplastic Syndrome
Myelodysplastic syndrome (MDS) is often associated with autoimmune paraneoplastic manifestations. Seronegative arthritis is among one of them. Very rarely, pseudogout demonstrated as paraneoplastic autoimmune manifestations of MDS has been adumbrated so far. Our case would be the another addition in the series. Our patient is an 83-year-old male lately diagnosed with MDS. After six months of initial diagnosis, he had a sudden onset episode of pain and swelling involving left wrist. Synovial fluid analysis from respective radiocarpal joint confirmed the presence of intracellular positively birefringent rhomboid shaped crystals of calcium pyrophosphate dihydrate (CPPD). This was followed by another two flares of pseudogout involving right knee and lumbar spine at separate time intervals. Each of the episodes mentioned above responded well to intravenous and oral steroids. After the third bout, he was started treatment with azacitidine which showed effective abatement of further episodes of pseudogout up until now.